VEGF with AMD3100 endogenously mobilizes mesenchymal stem cells and improves fracture healing

被引:19
|
作者
Meeson, Richard [1 ,2 ]
Sanghani-Keri, Anita [1 ]
Coathup, Melanie [1 ,3 ]
Blunn, Gordon [1 ,4 ]
机构
[1] Univ Coll London, Div Surg, Stanmore, Middx, England
[2] Royal Vet Coll, Hatfield, Herts, England
[3] Univ Cent Florida, Orlando, FL 32816 USA
[4] Univ Portsmouth, Portsmouth, Hants, England
基金
英国医学研究理事会;
关键词
mobilization; mesenchymal stem cells; AMD3100; VEGF; fracture healing; BONE-MARROW; PERIPHERAL-BLOOD; PROGENITOR CELLS; IN-VIVO; BIOLOGICAL CHARACTERISTICS; PRECURSOR CELLS; ANGIOGENESIS; MIGRATION; REPAIR; ANTAGONIST;
D O I
10.1002/jor.24164
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
A significant number of fractures develop non-union. Mesenchymal stem cell (MSC) therapy may be beneficial, however, this requires cell acquisition, culture and delivery. Endogenous mobilization of stem cells offers a non-invasive alternative. The hypothesis was administration of VEGF and the CXCR4 antagonist AMD3100 would increase the circulating pool of available MSCs and improve fracture healing. Ex-breeder female wistar rats received VEGF followed by AMD3100, or sham PBS. Blood prepared for culture and colonies were counted. P3 cells were analyzed by flow cytometry, bi-differentiation. The effect of mobilization on fracture healing was evaluated with 1.5 mm femoral osteotomy stabilized with an external fixator in 12-14 week old female Wistars. The mobilized group had significantly greater number of cfus/ml compared to controls, p = 0.029. The isolated cells expressed 1.8% CD34, 35% CD45, 61% CD29, 78% CD90, and differentiated into osteoblasts but not into adipocytes. The fracture gap in animals treated with VEGF and AMD3100 showed increased bone volume; 5.22 +/- 1.7 mu m(3) and trabecular thickness 0.05 +/- 0.01 mu m compared with control animals (4.3 +/- 3.1 mu m(3), 0.04 +/- 0.01 mu m, respectively). Radiographic scores quantifying fracture healing (RUST) showed that the animals in the mobilization group had a higher healing score compared to controls (9.6 vs. 7.7). Histologically, mobilization resulted in significantly lower group variability in bone formation (p = 0.032) and greater amounts of bone and less fibrous tissue than the control group. Clinical significance: This pre-clinical study demonstrates a beneficial effect of endogenous MSC mobilization on fracture healing, which may have translation potential to prevent or treat clinical fractures at risk of delayed or non-union fractures. (c) 2018 The Authors. Journal of Orthopaedic Research (R) Published by Wiley Periodicals, Inc. on behalf of Orthopaedic Research Society. J Orthop Res 37:1294-1302, 2019.
引用
收藏
页码:1294 / 1302
页数:9
相关论文
共 50 条
  • [1] Potent stem cell mobilization by AMD3100 infusion, and functional analysis of AMD3100 mobilized cells
    Bonig, H.
    Papayannopoulou, T.
    VOX SANGUINIS, 2008, 95 : 27 - 27
  • [2] AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates
    Larochelle, A
    Krouse, A
    Metzger, M
    Orlic, D
    Donahue, RE
    Fricker, S
    Bridger, G
    Dunbar, CE
    Hematti, P
    BLOOD, 2006, 107 (09) : 3772 - 3778
  • [3] The effects of AMD3100 on diabetic wound healing
    Allen, Robert J., Jr.
    Lin, Clarence D.
    Nguyen, Phuong D.
    Garfein, Evan
    Warren, Stephen M.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2008, 207 (03) : S59 - S59
  • [4] The Combination of AMD3100 Plus GROβ Rapidly Mobilizes Hematopoietic Stem Cells with Enhanced Homing, Adhesion and Survival Properties
    Pelus, Louis M.
    Singh, Pratibha
    BLOOD, 2008, 112 (11) : 34 - 34
  • [5] AMD3100 leads to improved diabetic wound healing
    Allen, Robert J., Jr.
    Lin, Clarence D.
    Nyguen, Phoung D.
    Garfein, Evan
    Warren, Stephen M.
    WOUND REPAIR AND REGENERATION, 2008, 16 (02) : A56 - A56
  • [6] Maximizing mobilization of hematopoietic stem and progenitor cells (HSPC) by AMD3100 and characterization of phenotype, function and cell cycling of AMD3100 mobilized HSPC
    Bonig, H.
    Papayannopoulou, T.
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (09) : 49 - 49
  • [7] THE USE OF AMD3100 FOR BONE MARROW DERIVED MESENCHYMAL STEM CELLS MOBILIZATION IN THE TREATMENT OF ASHERMAN'S SYNDROME
    Flores, Valerie A.
    Delis, Pablo
    Mamillapalli, Ramanaiah
    Taylor, Hugh S.
    FERTILITY AND STERILITY, 2024, 122 (04) : E36 - E37
  • [8] AMD3100 improves ovariectomy-induced osteoporosis in mice by facilitating mobilization of hematopoietic stem/progenitor cells
    Im, Jin Young
    Min, Woo-Kie
    Park, Min Hee
    Kim, NamOh
    Lee, Jong Kil
    Jin, Hee Kyung
    Choi, Je-Yong
    Kim, Shin-Yoon
    Bae, Jae-sung
    BMB REPORTS, 2014, 47 (08) : 439 - 444
  • [9] AMD3100 MOBILIZES A MORE PRIMITIVE HEMATOPOIETIC PROGENITOR SUBSET FROM HUMAN MARROW
    Wagner, W.
    Fruehauf, S.
    Callandra, G.
    Ho, A. D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 94 - 94
  • [10] Improved bony healing with AMD3100 via neovascularization and osteogenesis
    Paek, Gina K.
    Wang, XiaoXia
    Allen, Robert J., Jr.
    Nguyen, Phuong D.
    Davidson, Edward H.
    Tutela, John P.
    Sailon, Alexander
    Saadeh, Pierre B.
    Warren, Stephen M.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 209 (03) : S62 - S63